Pacific biosciences of california stock.
Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.
Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ...Feb 10, 2021 · The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session. Nov 13, 2023 · Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) reported Loss for second quarter that decreased from the same period last year and beat the Street estimates. The company's bottom line ...The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks.
Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.
Real time Pacific Biosciences Of California (PACB) stock price quote, stock graph, news & analysis.Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...If you live in California, chances are you get your electricity and gas services from Pacific Gas and Electric Company (PG&E). As a PG&E customer, you receive a monthly bill for your energy usage.٢٧/٠١/٢٠٢٣ ... The common stock is listed on the Nasdaq Global Select Market under the symbol “PACB”. Based in Menlo Park, California, Pacific Biosciences ...Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...
24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...
Nov 27, 2023 · Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings Preview
٠٣/٠٤/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.Pacific Biosciences of California Inc (NASDAQ: PACB) has experienced a rise in its stock price by 4.67 compared to its previous closing price of 8.36. However, the company has seen a gain of 15.28% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-20 that Pacific Biosciences reported a 72% YoY […]٢٠/١١/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Dec 1, 2023 · The low in the last 52 weeks of Pacific Biosciences of California stock was 5.74. According to the current price, Pacific Biosciences of California is 155.92% away from the 52-week low. Get a real-time Pacific Biosciences of California, Inc. (PACB) stock price quote with breaking news, financials, statistics, charts and more.
Detailed statistics for Pacific Biosciences of California, Inc. (PACB) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has decreased by -6.98% in the last 52 weeks. The beta is 1.72, so PACB's price volatility has been higher than the market average. Beta (1Y)Pacific Biosciences of California Inc’s price is currently up 5.51% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.The firm now holds 59,626 shares of the biotechnology company’s stock, after selling 59,343 shares in the quarter. According to financial data as of the end of the reporting period, these holdings were valued at $793,000. Pacific Biosciences of California is a renowned biotechnology company that specializes in genetic sequencing …Jan 25, 2023 · Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ... Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from ...Apr 11, 2023 · Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...
Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.
Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Jan, 2023, 16:05 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 ...MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.In other Pacific Biosciences of California news, insider Christian O. Henry sold 96,844 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $10.12, for a total value of $980,061.28.Pacific Biosciences of California, Inc. has a twelve month low of $5.74 and a twelve month high of $14.55. The stock has a market cap of $2.37 billion, a P/E ratio of -6.99 and a beta of 1.78. The ...Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ...Nov 24, 2023 · 11 analysts have issued 1 year price objectives for Pacific Biosciences of California's stock. Their PACB share price targets range from $8.00 to $17.00. On average, they predict the company's stock price to reach $11.80 in the next year. This suggests a possible upside of 38.0% from the stock's current price. ٢٧/٠١/٢٠٢٣ ... The common stock is listed on the Nasdaq Global Select Market under the symbol “PACB”. Based in Menlo Park, California, Pacific Biosciences ...Of course Pacific Biosciences of California may not be the best stock to buy.So you may wish to see this free collection of growth stocks.. Please note, the market returns quoted in this article ...
Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. Revio system is a product with long-read ...
See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.
Mar 31, 2023 · Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s stock price dropped 4% on Monday .The company traded as low as $8.14 and last traded at $8.21. Approximately 282,223 ...Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue growth in ...Apr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ... PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...Nov 16, 2023 · Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Pacific Biosciences of California (PACB) (Delayed Data from NSDQ) $8.55 USD +0.19 (2.27%) Updated Nov 24, 2023 01:00 PM ET After-Market: $8.72 +0.17 …
MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, …Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.Instagram:https://instagram. spts etffcnvxamzmcontemporary art investment A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a … reddit daytradingdo it yourself financial planning software Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue …Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... parg stock forecast Nov 2, 2023 · Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected]. MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.